These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 32407492)

  • 1. Determination of the time-dependent association between ciprofloxacin consumption and ciprofloxacin resistance using a weighted cumulative exposure model compared with standard models.
    van Gaalen RD; Altorf-van der Kuil W; Wegdam-Blans MCA; Aguilar Diaz JM; Beauchamp ME; Chaname Pinedo LE; de Greeff SC; Wallinga J
    J Antimicrob Chemother; 2020 Aug; 75(8):2326-2333. PubMed ID: 32407492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The weighted cumulative exposure method and its application to pharmacoepidemiology: A narrative review.
    Kelly TL; Salter A; Pratt NL
    Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5701. PubMed ID: 37749615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population.
    Mulder M; Kiefte-de Jong JC; Goessens WH; de Visser H; Hofman A; Stricker BH; Verbon A
    J Antimicrob Chemother; 2017 Jan; 72(1):281-289. PubMed ID: 27655855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.
    Fox MT; Melia MT; Same RG; Conley AT; Tamma PD
    Am J Med; 2017 Jul; 130(7):842-845. PubMed ID: 28216442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
    Ten Doesschate T; van Mens SP; van Nieuwkoop C; Geerlings SE; Hoepelman AIM; Bonten MJM
    BMC Infect Dis; 2018 Dec; 18(1):626. PubMed ID: 30518334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroxime.
    Jensen JU; Hein L; Lundgren B; Bestle MH; Mohr T; Andersen MH; Løken J; Tousi H; Søe-Jensen P; Lauritsen AØ; Strange D; Petersen JA; Thormar K; Larsen KM; Drenck NE; Helweg-Larsen J; Johansen ME; Reinholdt K; Møller JK; Olesen B; Arendrup MC; Østergaard C; Cozzi-Lepri A; Grarup J; Lundgren JD;
    Crit Care Med; 2015 Mar; 43(3):594-602. PubMed ID: 25493970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model.
    Perrin-Guyomard A; Poul JM; Laurentie M; Sanders P; Fernández AH; Bartholomew M
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):66-78. PubMed ID: 16563587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposure.
    Bally M; Beauchamp ME; Abrahamowicz M; Nadeau L; Brophy JM
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):69-77. PubMed ID: 29171096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy.
    Morales D; Pacurariu A; Slattery J; Pinheiro L; McGettigan P; Kurz X
    JAMA Neurol; 2019 Jul; 76(7):827-833. PubMed ID: 31034074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin.
    Lista F; Redondo C; Meilán E; García-Tello A; Ramón de Fata F; Angulo JC
    Actas Urol Esp; 2014; 38(6):391-6. PubMed ID: 24775812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.
    Marwick CA; Yu N; Lockhart MC; McGuigan CC; Wiuff C; Davey PG; Donnan PT
    J Antimicrob Chemother; 2013 Dec; 68(12):2927-33. PubMed ID: 23825381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing trend in gonococcal resistance to ciprofloxacin in The Netherlands, 2006-8.
    Koedijk FD; van Veen MG; de Neeling AJ; Linde GB; van der Sande MA
    Sex Transm Infect; 2010 Feb; 86(1):41-5. PubMed ID: 19703843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does ciprofloxacin prophylaxis during chemotherapy induce intestinal microflora resistance to ceftazidime in children with cancer?
    Tunyapanit W; Chelae S; Laoprasopwattana K
    J Infect Chemother; 2018 May; 24(5):358-362. PubMed ID: 29426774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hepatotoxicity associated with fluoroquinolones: a national case-control safety study.
    Alshammari TM; Larrat EP; Morrill HJ; Caffrey AR; Quilliam BJ; LaPlante KL
    Am J Health Syst Pharm; 2014 Jan; 71(1):37-43. PubMed ID: 24352180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.
    Vellinga A; Tansey S; Hanahoe B; Bennett K; Murphy AW; Cormican M
    J Antimicrob Chemother; 2012 Oct; 67(10):2523-30. PubMed ID: 22729920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea.
    Cho Y; Park HS
    BMJ Open; 2018 Sep; 8(9):e020974. PubMed ID: 30269062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department.
    Bischoff S; Walter T; Gerigk M; Ebert M; Vogelmann R
    BMC Infect Dis; 2018 Jan; 18(1):56. PubMed ID: 29373965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice.
    Vellinga A; Murphy AW; Hanahoe B; Bennett K; Cormican M
    J Antimicrob Chemother; 2010 Jul; 65(7):1514-20. PubMed ID: 20457673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.